{"id":388326,"date":"2026-06-24T11:00:08","date_gmt":"2026-06-24T05:30:08","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=388326"},"modified":"2026-06-24T10:31:42","modified_gmt":"2026-06-24T05:01:42","slug":"shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/","title":{"rendered":"<p style=\"font-family: ED Garamond;\">Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement<\/p>"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%; font-family: ED Garamond;\">Shardul Amarchand Mangaldas &amp; Co. (SAM) advised Krishna Institute of Medical Sciences Limited (KIMS), one of the key healthcare corporate groups in India, on its Qualified Institutions Placement (QIP) aggregating to &#8377;1,500 crore (approx. USD 158 million).<\/p>\n<p style=\"margin-bottom: 3%; font-family: ED Garamond;\">The QIP comprised participation from a diverse set of institutional investors, including the International Finance Corporation (IFC), as well as leading mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance and Kotak Mahindra Life Insurance.<\/p>\n<p style=\"margin-bottom: 3%; font-family: ED Garamond;\">The proceeds of the QIP are proposed to be utilised towards repayment and\/or prepayment of certain outstanding borrowings availed by the Company and certain of its subsidiaries.<\/p>\n<p style=\"margin-bottom: 3%; font-family: ED Garamond;\">The transaction team comprised of Prashant Gupta, <span style=\"font-style: italic;\">Partner<\/span> <span style=\"font-style: italic;\">and National Practice Head &#8211; Capital Markets<\/span>, Ruth Chenchiah, <span style=\"font-style: italic;\">Partner<\/span>, Ritika Khare, <span style=\"font-style: italic;\">Principal Associate<\/span>; Anoushka PV, <span style=\"font-style: italic;\">Senior Associate<\/span>; Anaya Jain, <span style=\"font-style: italic;\">Associate<\/span>; and Kunika Agarwal, <span style=\"font-style: italic;\">Associate<\/span>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">The QIP comprised participation from a diverse set of institutional investors, including the International Finance Corporation (IFC), as well as leading mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance and Kotak Mahindra Life Insurance.<\/p>\n","protected":false},"author":67011,"featured_media":388327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45282,2],"tags":[104678,93577,102421,102148,108015,108016,96950,108012,108011,108010,46749,108017,108014,108013],"class_list":["post-388326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-capital-markets-transaction","tag-equity-capital-markets-india","tag-equity-placement-india","tag-healthcare-sector-fundraising","tag-hospital-chain-financing","tag-india-healthcare-ipo-alternatives","tag-institutional-investors-qip","tag-kims-qip","tag-krishna-institute-of-medical-sciences-ltd","tag-qip-1500-crore","tag-qualified-institutional-placement","tag-sam-legal-advisory-deal","tag-sebi-listed-company-fundraise","tag-shardul-amarchand-mangaldas-deal"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shardul Amarchand Mangaldas Advises KIMS on \u20b91,500 Crore Qualified Institutions Placement<\/title>\n<meta name=\"description\" content=\"Shardul Amarchand Mangaldas advised Krishna Institute of Medical Sciences Ltd on its \u20b91,500 crore Qualified Institutions Placement (QIP), marking a significant capital markets transaction in the Indian healthcare sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its \u20b91,500 Crore Qualified Institutions Placement\" \/>\n<meta property=\"og:description\" content=\"Shardul Amarchand Mangaldas advised Krishna Institute of Medical Sciences Ltd on its \u20b91,500 crore Qualified Institutions Placement (QIP), marking a significant capital markets transaction in the Indian healthcare sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-24T05:30:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"&lt;p style=&quot;font-family: ED Garamond;&quot;&gt;Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement&lt;\/p&gt;\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement\",\"datePublished\":\"2026-06-24T05:30:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/\"},\"wordCount\":161,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/KIMS-\u20b91500-crore-QIP.webp\",\"keywords\":[\"capital markets transaction\",\"Equity Capital Markets India\",\"equity placement India\",\"Healthcare Sector Fundraising\",\"hospital chain financing\",\"India healthcare IPO alternatives\",\"institutional investors QIP\",\"KIMS QIP\",\"Krishna Institute of Medical Sciences Ltd\",\"QIP \u20b91500 crore\",\"Qualified Institutional Placement\",\"SAM legal advisory deal\",\"SEBI listed company fundraise\",\"Shardul Amarchand Mangaldas deal\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/\",\"name\":\"Shardul Amarchand Mangaldas Advises KIMS on \u20b91,500 Crore Qualified Institutions Placement\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/KIMS-\u20b91500-crore-QIP.webp\",\"datePublished\":\"2026-06-24T05:30:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Shardul Amarchand Mangaldas advised Krishna Institute of Medical Sciences Ltd on its \u20b91,500 crore Qualified Institutions Placement (QIP), marking a significant capital markets transaction in the Indian healthcare sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/KIMS-\u20b91500-crore-QIP.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/KIMS-\u20b91500-crore-QIP.webp\",\"width\":886,\"height\":590,\"caption\":\"KIMS \u20b91500 crore QIP\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/06\\\/24\\\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Mangaldas Advises KIMS on \u20b91,500 Crore Qualified Institutions Placement","description":"Shardul Amarchand Mangaldas advised Krishna Institute of Medical Sciences Ltd on its \u20b91,500 crore Qualified Institutions Placement (QIP), marking a significant capital markets transaction in the Indian healthcare sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its \u20b91,500 Crore Qualified Institutions Placement","og_description":"Shardul Amarchand Mangaldas advised Krishna Institute of Medical Sciences Ltd on its \u20b91,500 crore Qualified Institutions Placement (QIP), marking a significant capital markets transaction in the Indian healthcare sector.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2026-06-24T05:30:08+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"<p style=\"font-family: ED Garamond;\">Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement<\/p>","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement","datePublished":"2026-06-24T05:30:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/"},"wordCount":161,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.webp","keywords":["capital markets transaction","Equity Capital Markets India","equity placement India","Healthcare Sector Fundraising","hospital chain financing","India healthcare IPO alternatives","institutional investors QIP","KIMS QIP","Krishna Institute of Medical Sciences Ltd","QIP \u20b91500 crore","Qualified Institutional Placement","SAM legal advisory deal","SEBI listed company fundraise","Shardul Amarchand Mangaldas deal"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/","url":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/","name":"Shardul Amarchand Mangaldas Advises KIMS on \u20b91,500 Crore Qualified Institutions Placement","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.webp","datePublished":"2026-06-24T05:30:08+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Shardul Amarchand Mangaldas advised Krishna Institute of Medical Sciences Ltd on its \u20b91,500 crore Qualified Institutions Placement (QIP), marking a significant capital markets transaction in the Indian healthcare sector.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.webp","width":886,"height":590,"caption":"KIMS \u20b91500 crore QIP"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/06\/24\/shardul-amarchand-mangaldas-krishna-institute-medical-sciences-qip-1500-crore\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its &#8377;1,500 Crore Qualified Institutions Placement"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/06\/KIMS-\u20b91500-crore-QIP.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/388326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=388326"}],"version-history":[{"count":2,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/388326\/revisions"}],"predecessor-version":[{"id":388330,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/388326\/revisions\/388330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/388327"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=388326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=388326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=388326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}